Clinical Trial Update: A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the use of melphalan in lymphoma patients undergoing autologous hematopoietic cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Hodgkin Lymphoma
• Lymphoma
• Non-hodgkin Lymphoma
• T-cell Lymphoma

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lymphoma, Lymphoma, B-Cell | Phase 1 | Status: ACTIVE_NOT_RECRUITING